LIVANOVA PLC (LIVN) Stock Fundamental Analysis

NASDAQ:LIVN • GB00BYMT0J19

70.27 USD
-0.33 (-0.47%)
At close: Mar 2, 2026
70.62 USD
+0.35 (+0.5%)
After Hours: 3/2/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIVN. LIVN was compared to 184 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year LIVN was profitable.
  • LIVN had a positive operating cash flow in the past year.
  • In multiple years LIVN reported negative net income over the last 5 years.
  • In the past 5 years LIVN always reported a positive cash flow from operatings.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • LIVN has a Return On Assets of -9.30%. This is in the better half of the industry: LIVN outperforms 62.50% of its industry peers.
  • The Return On Equity of LIVN (-20.21%) is better than 61.41% of its industry peers.
  • LIVN's Return On Invested Capital of 8.12% is amongst the best of the industry. LIVN outperforms 83.70% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LIVN is below the industry average of 8.75%.
  • The last Return On Invested Capital (8.12%) for LIVN is above the 3 year average (5.19%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROIC 8.12%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • The Operating Margin of LIVN (14.69%) is better than 82.61% of its industry peers.
  • LIVN's Operating Margin has improved in the last couple of years.
  • LIVN has a Gross Margin of 68.04%. This is in the better half of the industry: LIVN outperforms 74.46% of its industry peers.
  • In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 14.69%
PM (TTM) N/A
GM 68.04%
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
  • LIVN has more shares outstanding than it did 1 year ago.
  • LIVN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LIVN has been reduced compared to a year ago.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.96 indicates that LIVN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • LIVN has a Altman-Z score (1.96) which is in line with its industry peers.
  • The Debt to FCF ratio of LIVN is 2.17, which is a good value as it means it would take LIVN, 2.17 years of fcf income to pay off all of its debts.
  • LIVN's Debt to FCF ratio of 2.17 is amongst the best of the industry. LIVN outperforms 86.96% of its industry peers.
  • LIVN has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • LIVN has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Altman-Z 1.96
ROIC/WACC0.93
WACC8.76%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that LIVN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.36, LIVN is not doing good in the industry: 78.80% of the companies in the same industry are doing better.
  • LIVN has a Quick Ratio of 1.16. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.16, LIVN is doing worse than 70.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.16
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.73% over the past year.
  • Measured over the past years, LIVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.16% on average per year.
  • The Revenue has grown by 10.74% in the past year. This is quite good.
  • LIVN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.24% yearly.
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%

3.2 Future

  • LIVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.22% yearly.
  • Based on estimates for the next years, LIVN will show a small growth in Revenue. The Revenue will grow by 6.71% on average per year.
EPS Next Y8.11%
EPS Next 2Y7.93%
EPS Next 3Y9.97%
EPS Next 5Y13.22%
Revenue Next Year6.68%
Revenue Next 2Y6.6%
Revenue Next 3Y6.86%
Revenue Next 5Y6.71%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.02, LIVN is valued on the expensive side.
  • Based on the Price/Earnings ratio, LIVN is valued cheaper than 85.33% of the companies in the same industry.
  • LIVN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
  • With a Price/Forward Earnings ratio of 16.67, LIVN is valued correctly.
  • Based on the Price/Forward Earnings ratio, LIVN is valued cheaper than 86.96% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. LIVN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.02
Fwd PE 16.67
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaper than 82.61% of the companies in the same industry.
  • LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 88.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.14
EV/EBITDA 14.37
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LIVN does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)2.22
PEG (5Y)0.72
EPS Next 2Y7.93%
EPS Next 3Y9.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVANOVA PLC

NASDAQ:LIVN (3/2/2026, 8:00:02 PM)

After market: 70.62 +0.35 (+0.5%)

70.27

-0.33 (-0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners105.72%
Inst Owner Change-2.15%
Ins Owners0.28%
Ins Owner Change0.56%
Market Cap3.84B
Revenue(TTM)1.39B
Net Income(TTM)-242.47M
Analysts82.35
Price Target73.19 (4.16%)
Short Float %4.48%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.93%
Min EPS beat(2)3.44%
Max EPS beat(2)18.42%
EPS beat(4)4
Avg EPS beat(4)13.83%
Min EPS beat(4)3.44%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)17.63%
EPS beat(12)11
Avg EPS beat(12)17.8%
EPS beat(16)14
Avg EPS beat(16)14%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.14%
Max Revenue beat(2)2.12%
Revenue beat(4)4
Avg Revenue beat(4)2.26%
Min Revenue beat(4)0.14%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.08%
Revenue beat(12)11
Avg Revenue beat(12)3.31%
Revenue beat(16)14
Avg Revenue beat(16)2.76%
PT rev (1m)0.25%
PT rev (3m)6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.1%
EPS NY rev (1m)0%
EPS NY rev (3m)0.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 18.02
Fwd PE 16.67
P/S 2.76
P/FCF 22.14
P/OCF 15.09
P/B 3.2
P/tB 21.66
EV/EBITDA 14.37
EPS(TTM)3.9
EY5.55%
EPS(NY)4.22
Fwd EY6%
FCF(TTM)3.17
FCFY4.52%
OCF(TTM)4.66
OCFY6.63%
SpS25.42
BVpS21.97
TBVpS3.24
PEG (NY)2.22
PEG (5Y)0.72
Graham Number43.91
Profitability
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROCE 11.34%
ROIC 8.12%
ROICexc 12.57%
ROICexgc 104.62%
OM 14.69%
PM (TTM) N/A
GM 68.04%
FCFM 12.48%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
ROICexc(3y)7.23%
ROICexc(5y)5.51%
ROICexgc(3y)42.15%
ROICexgc(5y)N/A
ROCE(3y)7.24%
ROCE(5y)5.79%
ROICexgc growth 3Y126.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.54%
ROICexc growth 5YN/A
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Debt/EBITDA 1.38
Cap/Depr 175.19%
Cap/Sales 5.84%
Interest Coverage 6.56
Cash Conversion 101.65%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.16
Altman-Z 1.96
F-Score5
WACC8.76%
ROIC/WACC0.93
Cap/Depr(3y)118.73%
Cap/Depr(5y)92.37%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
EPS Next Y8.11%
EPS Next 2Y7.93%
EPS Next 3Y9.97%
EPS Next 5Y13.22%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%
Revenue Next Year6.68%
Revenue Next 2Y6.6%
Revenue Next 3Y6.86%
Revenue Next 5Y6.71%
EBIT growth 1Y25.59%
EBIT growth 3Y35.73%
EBIT growth 5YN/A
EBIT Next Year26.96%
EBIT Next 3Y-1.47%
EBIT Next 5Y-0.2%
FCF growth 1Y27.48%
FCF growth 3Y58.64%
FCF growth 5YN/A
OCF growth 1Y38.95%
OCF growth 3Y53.79%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 5 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 8.11% in the next year.